ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,992.72
0.67%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. HUTCHMED China Limited (HCM) Share Price

HCM HUTCHMED China Limited

18.73
0.01 (0.05%)
25 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 HUTCHMED China Limited NASDAQ:HCM NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.01 0.05 18.73 18.06 18.88 18.86 18.11 18.11 92,595 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 838M 100.78M - N/A 
 Type  Size  Price  Time  Units 
 9 42 18.73 20:00:10 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore HCM News
24/05/202411:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
24/05/202401:00GLOBEHUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting
17/05/202415:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
17/05/202415:00GLOBEHUTCHMED announces retirement of Chairman, appointment of new Chairman and change of members of board committees
17/05/202401:00GLOBEHUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
14/05/202401:00GLOBEHUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China
14/05/202401:00GLOBEHUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
14/05/202403:17PBB(Chi-Med)Hutchinson China Meditech Limited4,046
25/03/202217:25PBBHutchison Chi-Med (HCM) One to Watch 4
23/07/201810:55PBBHutchison Chi-Med (HCM) One to Watch on Monday 2
13/06/201707:54PBBHutchison China Meditech- CHARTS AND DISCUSSION75
Data Downloads for HCM

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest HUTCHMED China Limited Articles